MSLN and malignant mesothelioma: Importantly, a sandwich ELISA combining YP218 and YP223 brought the detection limit of soluble mesothelin (<0.01 nM) to 250-fold lower than the threshold between healthy people and malignant mesothelioma patients (>2.5 nM in serum34 and >20 nM in plueural effusions35).